Diagnostic utility of oxidative damage markers for early rheumatoid arthritis in non-smokers and negative anti-CCP patients
DOI:
https://doi.org/10.23938/ASSN.0360Keywords:
Sensitivity. Lipid hydroperoxide. Carbonyl protein. Smoking. Rheumatoid arthritis.Abstract
Background. Besides the development of new markers and diagnostic criteria for rheumatoid arthritis (RA), many patients are still diagnosed after several years of symptoms. Oxidative stress markers are already increased at an early stage of RA. Our aim was to evaluate the additional diagnostic value of these markers.
Methods.A case-control study was performed. Patients met the 1987 RA ACR criteria, less than 2 years of symptoms and no previous treatment with disease-modifying anti-rheumatic drugs (DMARD), steroids or vitamin E. Controls were selected from patient’s relatives and matched (1:1) by gender, age, and current smoking habit. Oxidative damage markers were malonyldialdehyde (MDA), Lipid hydroperoxides (LOOH) and Carbonyl proteins (CP). Statistical analysis was performed in agreement with the STARD initiative.
Results.Sixty-five RA patients without treatment and 65 healthy controls were included. LOOH, CP, antibodies against citrullinated peptides (anti-CCP) and rheumatoid factor (RF) were significantly higher in patients, and MDA higher in controls. The same results were obtained in the subgroups of patients who smoke or not, and in anti-CCP positive or negative. The diagnosis performance of traditional markers showed good specificity but low sensitivity. The addition of LOOH and CP increased the sensitivity and the area under the receiving operating characteristic (ROC) curve especially in non-smoking (66%) and negative anti-CCP (51%) patients.
Conclusions.The separate or combined addition of LOOH or CP to the traditional disease markers improved the diagnosis of RA, especially in non-smoking or negative anti-CCP patients.Downloads
References
1. ALETAHA D, NEOGI T, SILMAN AJ, FUNOVITS J, FELSON DT, BINGHAM CO et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010; 69: 1580-1588.
https://doi.org/10.1136/ard.2010.138461
2. KLARESKOG L, PADYUKOV L, ALFREDSSON L. Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 2007; 19: 49-54.
https://doi.org/10.1097/BOR.0b013e32801127c8
3. KÄLLBERG H, DING B, PADYUKOV L, BENGTSSON C, RÖNNELID J, KLARESKOG L, ALFREDSSON L. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 2001; 70: 508-511.
https://doi.org/10.1136/ard.2009.120899
4. COSTENBADER KH, KARLSON EW. Lupus 2006; 15: 737-745.
https://doi.org/10.1177/0961203306069344
5. CEDERGREN J, FORSLUND T, SUNDQVIST T, SKOGH T. Intracellular oxidative activation in synovial fluid neutrophils from patients with rheumatoid arthritis but not from other arthritis patients. J Rheumatol 2007; 34: 2162-2170.
6. SARBAN S, KOCYIGIT A, YAZAR M, ISIKAN UE. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 2005; 38: 981-986.
https://doi.org/10.1016/j.clinbiochem.2005.08.003
7. CERHAN JR, SAAG KG, MERLINO LA, MIKULS TR, CRISWELL LA. Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol 2003; 157: 345-54.
https://doi.org/10.1093/aje/kwf205
8. COMSTOCK GW, BURKE AE, HOFFMAN SC, HELZLSONER KJ, BENDICH A, MASI AT et al. Serum concentrations of alpha tocopherol, beta carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1997; 56: 323-325.
https://doi.org/10.1136/ard.56.5.323
9. BOSSUTY PM, REITSMA JB, BRUNS DE, GATSONIS CA, GLASZIOU PP, IRWING LM et al. Towars complete an accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med 2003; 138: 40-44.
https://doi.org/10.7326/0003-4819-138-1-200301070-00010
10. MATSUI T, SHIMADA K, OZAWA N, HAYAKAWA H, HAGIWARA F, NAKAYAMA H et al. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. J Rheumatol 2006; 33: 2390-2397.
11. HODKINSON B, MUSENGE PWA, ALLY MMT, WADEE AA, ANDERSON R, TIKLY M. The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis. Clinical Rheumatology 2010; 29: 615-618.
https://doi.org/10.1007/s10067-010-1374-x
12. ISIK SS, KOCA B, USTUNDAG H, YILDIRIM AC. Paraoxonase and arylesterase levels in rheumatoid arthritis. Clin Rheumatol 2007; 26: 342-348.
https://doi.org/10.1007/s10067-006-0300-8
13. LEMARECHAL H, ALLANORE Y, CHENEVIER-GOBEAUX C, KAHAN A, EKINDJIAN OG, BORDERIE D. Serum protein oxidation in patients with rheumatoid arthritis and effects of infliximab therapy. Clin Chim Acta 2006; 372: 147-153.
https://doi.org/10.1016/j.cca.2006.04.002
14. NAVARRO-COMPÁN MV, MELGUIZO-MADRID E, HERNÁNDEZ-CRUZ B, SANTOS-REY K, LEYVA-PRADO C, GONZÁLEZ-MARTÍN C et al. Interaction between oxidative stress and smoking is associated with rheumatoid arthritis. A case - control study. Rheumatology 2013; 52: 487-493.
https://doi.org/10.1093/rheumatology/kes286
15. SEVEN A, GÜZEL S, ASLAN M, HAMURYUDAN V. Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. Clin Biochem 2008; 41: 538-543.
https://doi.org/10.1016/j.clinbiochem.2008.01.029
16. ZSUZSANNA B, BUZÁS E, NAGY G. Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Res Ther 2009; 11: 238-250.
https://doi.org/10.1186/ar2751
17. LEE DM, PHILLIPS R, HAGAN EM, CHIBNIK LB, COSTENBADER KH, SCHUR PH. Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Ann Rheum Dis 2009; 68: 201-208.
https://doi.org/10.1136/ard.2007.084509
18. KLARESKOG L, STOLT P, LUNDBERG K, KALLBERG H, BENGTSSON C, GRUNEWALD J. A New model for an etiology of rheumatoid arthritis. Smoking may trigger hla-dr (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54: 38-46.
https://doi.org/10.1002/art.21575
19. BENCINA MJ. Caution is needed in the interpretation of added value of biomarkers analyzed in matched case control studies. Clin Chem 2012; 58: 1176-1178.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
